An In Depth Study Evaluating The Experiences of Patients In Schizophrenia Research

Power Life Sciences Inc.500 enrolled

Overview

Historically, research participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively. Several people will be invited to enroll in this study so that it may collect a variety of data about schizophrenia clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. The data collected from this study will be analyzed and used to improve the experiences of future schizophrenia patients who are recruited for medical trials.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Schizophrenia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has self-identified as planning to enroll in a clinical trial * Patient has been diagnosed with schizophrenia * Patient is a minimum of 18 years or older Exclusion Criteria: * Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant

Outcomes

Primary Outcomes

Number of patients who decide to participate in a schizophrenia research

Time frame: 3 months

Rate of patients who remain in schizophrenia clinical trial to trial completion